Enko, a Mystic, CT-based crop health company, raised $80M in Series C funding.
The round, which brings overall capital raised to date to $150M. was led by Eight Roads Ventures, Nufarm, Endeavor8, and Akroyd LLC.
The company intends to use the funds to advance its product pipeline of novel crop protection chemistries and provide critical solutions for large scale global food security challenges.
Led by CEO Jacqueline Heard, Enko Chem designs safe and sustainable solutions to farmers’ crop threats, from pest resistance to new diseases by applying the latest drug discovery and development approaches from pharma to agriculture. Its product pipeline is currently led by a range of herbicides that are breaking cycles of weed and pest resistance and are being developed to reduce environmental load compared to current solutions.
Since its start in 2017, Enko has generated hundreds of leading molecules across all categories of crop protection through its ENKOMPASS™ technology platform, which combines DNA-encoded library screening with machine learning and structure-based design to quickly find new, better performing and more targeted chemistries.
